Ardent Health Partners, Inc.(ARDT)
$17.75-0.35 (-1.93%)
ARDT
Ardent Health Partners, Inc. financials statements
$17.75
At close:-0.35 (-1.93%)
Want to see ARDT full AI Analyst Report?
Ardent Health Partners, Inc. (ARDT) Ratios
106 Followers
Ardent Health Partners, Inc. Ratios
ARDT's free cash flow for Q3 2026 was $73.12M. For the 2026 fiscal year, ARDT's free cash flow was decreased by $-48.81M and operating cash flow was $121.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.97 | 1.94 | 1.63 | 1.74 | 1.38 |
| Quick Ratio | 1.85 | 1.82 | 1.52 | 1.61 | 1.24 |
| Cash Ratio | 0.68 | 0.59 | 0.44 | 0.56 | 0.10 |
| Solvency Ratio | 0.08 | 0.10 | 0.05 | 0.09 | 0.00 |
| Operating Cash Flow Ratio | 0.45 | 0.33 | 0.22 | -0.05 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 20.07 | 34.12 | 3.63 | -0.66 | 17.82 |
| Net Current Asset Value | $ -1.55B | $ -1.60B | $ -2.40B | $ -2.40B | $ -1.17B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.43 | 0.46 | 0.47 | 0.49 | 0.46 |
| Debt-to-Equity Ratio | 1.34 | 2.02 | 3.57 | 3.74 | 3.80 |
| Debt-to-Capital Ratio | 0.57 | 0.67 | 0.78 | 0.79 | 0.79 |
| Long-Term Debt-to-Capital Ratio | 0.39 | 0.49 | 0.63 | 0.64 | 0.79 |
| Financial Leverage Ratio | 3.14 | 4.38 | 7.61 | 7.60 | 8.28 |
| Debt Service Coverage Ratio | 5.61 | 6.84 | 2.59 | 3.46 | 2.19 |
| Interest Coverage Ratio | 5.90 | 6.19 | 3.51 | 2.65 | 1.38 |
| Debt to Market Cap | 0.88 | 0.48 | 0.53 | 0.53 | 0.56 |
| Interest Debt Per Share | 16.48 | 17.73 | 17.19 | 17.24 | 9.71 |
| Net Debt to EBITDA | 3.13 | 3.00 | 5.60 | 3.63 | 4.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 97.54% | 82.68% | 97.40% | 81.38% | 100.00% |
| EBIT Margin | 5.40% | 7.18% | 3.87% | 7.67% | 2.44% |
| EBITDA Margin | 7.86% | 9.64% | 6.47% | 10.37% | 5.90% |
| Operating Profit Margin | 5.15% | 6.80% | 4.24% | 4.23% | 3.60% |
| Pretax Profit Margin | 4.53% | 6.09% | 2.80% | 6.07% | -2.75% |
| Net Profit Margin | 2.15% | 3.53% | 0.93% | 3.68% | -3.44% |
| Continuous Operations Profit Margin | 3.64% | 5.02% | 2.38% | 5.17% | -2.48% |
| Net Income Per EBT | 47.43% | 57.94% | 33.17% | 60.65% | 124.79% |
| EBT Per EBIT | 87.95% | 89.48% | 66.06% | 143.52% | -76.53% |
| Return on Assets (ROA) | 2.57% | 4.24% | 0.99% | 3.89% | -5.21% |
| Return on Equity (ROE) | 8.05% | 18.59% | 7.50% | 29.56% | -43.13% |
| Return on Capital Employed (ROCE) | 7.67% | 10.12% | 5.59% | 5.36% | 7.06% |
| Return on Invested Capital (ROIC) | 6.13% | 8.24% | 4.68% | 4.50% | 6.34% |
| Return on Tangible Assets | 3.14% | 5.22% | 1.20% | 4.80% | -7.75% |
| Earnings Yield | 10.93% | 9.30% | 2.19% | 8.21% | -6.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.22 | 8.03 | 6.88 | 8.38 | 7.87 |
| Payables Turnover | 0.34 | 2.57 | 0.30 | 2.98 | 0.00 |
| Inventory Turnover | 1.31 | 8.98 | 1.34 | 8.91 | 0.00 |
| Fixed Asset Turnover | 2.95 | 2.93 | 2.69 | 2.58 | 4.96 |
| Asset Turnover | 1.20 | 1.20 | 1.06 | 1.06 | 1.52 |
| Working Capital Turnover Ratio | 6.66 | 7.90 | 8.83 | 0.00 | 17.91 |
| Cash Conversion Cycle | -755.89 | -55.64 | -903.42 | -38.10 | 46.40 |
| Days of Sales Outstanding | 39.60 | 45.46 | 53.02 | 43.54 | 46.40 |
| Days of Inventory Outstanding | 278.01 | 40.66 | 273.37 | 40.95 | 0.00 |
| Days of Payables Outstanding | 1073.50 | 141.76 | 1229.80 | 122.59 | 0.00 |
| Operating Cycle | 317.60 | 86.12 | 326.39 | 84.49 | 46.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.34 | 2.38 | 1.55 | -0.27 | 1.13 |
| Free Cash Flow Per Share | 1.84 | 0.96 | 0.59 | -1.32 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 2.22 | 1.68 | 1.61 | -0.12 | 0.99 |
| Capital Expenditure Coverage Ratio | 2.22 | 1.68 | 1.61 | -0.25 | 0.99 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.14 | 0.09 | -0.02 | 0.13 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.05 | 0.04 | -0.01 | 0.04 |
| Free Cash Flow Yield | 20.81% | 5.64% | 3.66% | -8.23% | -0.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.20 | 10.74 | 45.75 | 12.18 | -15.83 |
| Price-to-Sales (P/S) Ratio | 0.20 | 0.38 | 0.43 | 0.45 | 0.54 |
| Price-to-Book (P/B) Ratio | 0.74 | 2.00 | 3.43 | 3.60 | 6.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.81 | 17.74 | 27.30 | -12.14 | -2113.79 |
| Price-to-Operating Cash Flow Ratio | 2.64 | 7.18 | 10.38 | -59.98 | 14.19 |
| Price-to-Earnings Growth (PEG) Ratio | -0.23 | 0.03 | -0.62 | 0.55 | -0.05 |
| Enterprise Value Multiple | 5.63 | 6.94 | 12.17 | 7.96 | 14.10 |
| Enterprise Value | 2.80B | 3.99B | 4.26B | 4.23B | 3.47B |
| EV to EBITDA | 5.63 | 6.94 | 12.17 | 7.96 | 14.10 |
| EV to Sales | 0.44 | 0.67 | 0.79 | 0.83 | 0.83 |
| EV to Free Cash Flow | 10.82 | 31.27 | 50.54 | -22.34 | -3235.35 |
| EV to Operating Cash Flow | 5.95 | 12.66 | 19.21 | -110.35 | 21.71 |
| Tangible Book Value Per Share | 5.09 | 4.48 | 1.12 | 0.90 | -1.33 |
| Shareholders’ Equity Per Share | 11.98 | 8.54 | 4.68 | 4.46 | 2.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.17 | 0.15 | 0.15 | 0.10 |
| Revenue Per Share | 44.93 | 45.05 | 37.76 | 35.81 | 29.52 |
| Net Income Per Share | 0.96 | 1.59 | 0.35 | 1.32 | -1.01 |
| Tax Burden | 0.47 | 0.58 | 0.33 | 0.61 | 1.25 |
| Interest Burden | 0.84 | 0.85 | 0.72 | 0.79 | -1.13 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.65 | 0.67 | 0.66 | 0.64 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.04 | 1.05 | 1.72 | -0.14 | -1.12 |
Currency in USD

